Silverii, Giovanni Antonio http://orcid.org/0000-0002-6695-3213
Delli Poggi, Chiara
Dicembrini, Ilaria
Monami, Matteo
Mannucci, Edoardo
Funding for this research was provided by:
Università degli Studi di Firenze
Article History
Received: 4 April 2021
Accepted: 29 May 2021
First Online: 22 June 2021
Change Date: 21 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00592-021-01780-0
Declarations
:
: GAS and ID have received speaking fees from Astra Zeneca, Novonordisk, Eli Lilly outside the submitted work; CDP has no conflict of interest; MM has received speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi and Novartis and research grants from Bristol Myers Squibb outside the submitted work; EM has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi and Novartis and research grants from Merck, Novartis and Takeda outside the submitted work. All the authors approved the final version of this manuscript. Dr. Giovanni Antonio Silverii is the person who takes full responsibility for the work as a whole, including the study design, access to data and the decision to submit and publish the manuscript.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study formal consent is not required.